Comparative effectiveness of budesonide inhalation suspension and montelukast in mild asthma.
A new study published The Journal of Asthmaassessed that comparative effectiveness of low-dose budesonide inhalation suspension (BIS) versus oral montelukast (MON) in managing asthma control among children with mild asthma. This retrospective study analyzed claims from Koreas national health insurance database for children (2-17 years) with mild asthma (GINA 1 or 2) who initiated BIS or MON during 2015. Adherence, persistence, asthma control, asthma-related health-care resource utilizati
Read the full story.
Create a free account.
Sign Up to instantly read 30000+ free Articles & 1000+ Case Studies